Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.20.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2020
NET LOSS PER SHARE  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31, 

 

    

2020

    

2019

Warrants

 

9,268,352

 

5,318,747

Preferred shares as convertible into common stock

 

537,500

 

837,500

Stock options

 

884,464

 

198,784

Non-vested restricted stock

 

 

9,334

Total potentially dilutive shares

 

10,690,316

 

6,364,365